We currently support a number of clinical research studies, including:
ALIOS: This is an international study is looking at Pharmokinetics and safety profile of single of an antiviral study drug in otherwise healthy term infants between 1-12 months with proven RSV bronchiolitis. The single ascending and multiple ascending dosage phases of the trial are now completed and analysis of results from all international centres are awaited.
Regeneron Study: A Phase 3, Randomized, Double-blind, Placebo‑controlled Study Evaluating the Efficacy and Safety of a Human Monoclonal Antibody, REGN2222, for the Prevention of Medically Attended RSV Infection in Preterm Infants.
SANAD II Trial: This is a national trial comparing newer vs. older antiepileptic medication
Corticosteroid induced cataract in childhood steroid sensitive Nephrotic syndrome
For more information about these studies and other research in the area of General Paediatrics, please contact Easwari.Kothandaraman@cmft.nhs.uk
